GlaxoSmithKline today said it has agreed to buy Bristol-Myers Squibb Pakistan Ltd. and certain associated trademarks for around $36.5 million, bolstering its emerging markets business. Glaxo will ...
GSK committed $270 million up front in recent months to gain access to early-stage assets in the class of cancer therapies known as antibody drug conjugates, or ADCs. The deals are part of a broad ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results